Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://www.dovepress.com/lung-cancer-combination-therapy-doxorubicin-and-beta-elemene-co-loaded-peer-reviewed-fulltext-article-DDDT, but it redirected us to https://www.dovepress.com/lung-cancer-combination-therapy-doxorubicin-and-beta-elemene-co-loaded-peer-reviewed-fulltext-article-DDDT. The analysis below is for the second page.

Title[redir]:
Lung cancer combination therapy: doxorubicin and β-elemene co-loa | DDDT
Description:
Lung cancer combination therapy: doxorubicin and beta-elemene co-loaded, pH-sensitive nanostructured lipid carriers Chengsong Cao, Qun Wang, Yong LiuDepartment of Oncology, Xuzhou Center Hospital, Xuzhou, Jiangsu, People’s Republic of ChinaPurpose: Co-delivery of drugs to achieve the synergistic anticancer effect is a promising strategy for lung cancer therapy. The purpose of this research is to develop a doxorubicin (DOX) and β-elemene (ELE) co-loaded, pH-sensitive nanostructured lipid carriers (DOX/ELE Hyd NLCs).Methods: In this study, DOX/ELE Hyd NLCs were produced by a hot homogenization and ultrasonication method and used for lung cancer treatment. In vitro and in vivo efficiency as well as toxicity of the system was evaluated on lung cancer cell lines and lung tumor-bearing mice.Results: DOX/ELE Hyd NLCs had a particle size of 190 nm, with a PDI lower than 0.2. DOX/ELE Hyd NLCs exhibited a significantly enhanced cytotoxicity (drug concentration causing 50% inhibition was 7.86 μg/mL), synergy antitumor effect (combination index lower than 1), and profound tumor inhibition ability (tumor inhibition ratio of 82.9%) compared with the non pH-responsive NLCs and single-drug-loaded NLCs.Conclusion: Since the synergistic effect of the drugs was found in this system, it would have great potential to inhibit lung tumor cells and tumor growth.Keywords: lung cancer, combination therapy, pH-sensitive, nanostructured lipid carriers, doxorubicin, β-elemene

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌟 Strong Traffic: 100k - 200k visitors per month


Based on our best estimate, this website will receive around 100,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't figure out the monetization strategy.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

nlcs, doxele, cancer, hyd, drug, cells, tumor, lung, phsensitive, ele, lipid, dox, carriers, drugs, effect, nanostructured, therapy, vivo, figure, combination, release, βelemene, wang, nanoparticles, delivery, coloaded, doxorubicin, injection, aadr, synergistic, vitro, chemotherapy, zhang, cytotoxicity, inhibition, stability, measured, uptake, presented, anticancer, method, efficiency, cell, systems, study, results, antitumor, inj, cellular, tissue,

Topics {✒️}

ph-sensitive transferrin-peg-hz-lipid conjugate ph-sensitive nanostructured lipid carriers redox-sensitive lipid-polymer nanoparticles p-gp-dependent drug efflux ph-cleavable mpeg-hyd-dspe ph-sensitive curcumin prodrug advanced targeted therapies 2-distearoyl-sn-glycero-3-phosphoethanolamine 5-diphenyl-2-h-tetrazolium bromide perk/ire1α/atf6 pathway ph-sensitive hyaluronan nanoparticles ph-reversible lipopolyplex shielding ph-sensitive hydrazone bond small-cell lung cancer including fast-track processing single-drug-loaded nlcs dove medical press ph-sensitive nanoparticles represent lung tumor-bearing mice blank ph-sensitive nlcs ph-sensitive polymeric micelles drug-resistant cancer cells ph-sensitive micelles based dox-resistant a549 cells enhanced anti-tumor activity nanostructured lipid carriers manuscript login xuzhou center hospital dox/ele hyd nlcs long-lasting antitumor effect ph-sensitive carriers ph-sensitive hyd poorly water-soluble drugs acid-sensitive hydrazone human lung cancer favored authors specific author ph-sensitive nanoparticles mathematical model-based method ph-sensitive nanocarriers ph-sensitive nlcs transferrin-targeted nanoparticles ruixi biological technology drug delivery systems transferrin dual targeted c50-ele represent hybrid nanoparticles biodegradable lipid matrix lung cancer therapy successful cellular uptake

Questions {❓}

  • Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers?
  • Why publish with us?

Social Networks {👍}(9)

External Links {🔗}(165)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Tag Manager
  • Google Universal Analytics

Libraries {📚}

  • jQuery
  • Particles.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Com/cm/ef49a3f1-d8c1-47d6-88fc-50e41130631f/airgap

5.67s.